6 active trials 4 recruiting 1 disease areas
| Phase 1 | 3 | |
| Phase 1/2 | 2 | |
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT07028632 | The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's Disease | Parkinson Disease (PD) | Not Yet Recruiting | 2025-06-29 |
| Phase 1/2 | ||||
| NCT07102342 | This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and… | Parkinson Disease | Recruiting | 2026-05-11 |
| NCT06167681 | The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease | Parkinson Disease | Recruiting | 2024-11-01 |
| Phase 1 | ||||
| NCT07289477 | A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy | Multiple System Atrophy - Parkinsonian Subtype (MSA-P) | Recruiting | 2026-04-14 |
| NCT06608355 | The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset… | Early-onset Parkinson's Disease | Recruiting | 2024-11-07 |
| NCT07550374 | Phase I Clinical Study of NouvNeu001 Injection for the Treatment of Moderate-to-Advanced… | Parkinson's Disease (PD) | Not Yet Recruiting | 2026-04-24 |